Vaccinations
- PMID: 39437095
- Bookshelf ID: NBK608259
- DOI: 10.1007/978-3-031-44080-9_29
Vaccinations
Excerpt
Vaccination should be considered a routine practice for all HCT receptors, either autologous or allogeneic, adults or children. It should be implemented in all HCT programs. Adult cover is particularly important as they represent 90% of HCTs.
Copyright 2024, The Author(s).
Sections
- 29.1. General Concepts
- 29.2. General Principles of Vaccination in HCT Patients
- 29.3. Benefits and Risks of Vaccination in HCT Recipients
- 29.4. Vaccination Recommendations
- 29.5. Specific Vaccines
- 29.6. Vaccinations in Children Post-allogeneic Hematopoietic Cell Transplantation
- 29.7. Vaccinations Before Travel to Areas Endemic for Infections (See Table 29.2) (Ljungman et al. 2009)
- 29.8. Serological Testing
- 29.9. Vaccinations for Donors, Close Contacts/Family, and HCWs of HCT Recipients (See Table 29.3) (Ljungman et al. ; Cordonnier et al. ; Rubin et al. 2014)
- References
References
-
- Beck CR, McKenzie BC, Hashim AB, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by aetiology. J Infect Dis. 2012;206:1250–9. - PubMed
-
- Cesaro S, Ljungman P, Mikulska M, Hirsch HH, von Lilienfeld-Toal M, Cordonnier C, et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2022;36(6):1467–80. - PMC - PubMed
-
- Cesaro S, Mikulska M, Hirsh H, Styczynski J, Meylan S, Cordonnier C, et al. Update of recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2022 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2023;37(9):1933–8. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources